Deucravacitinib in the treatment of psoriasis by Tomás Estevinho, Ana Maria Lé, Tiago Torres

Subjects: Get full text

Portuguese Position Paper on the Use of Biosimilars in Psoriasis by Tiago Torres, Ana Ferreira, Paulo Ferreira, Martinha Henriques, Luiz Leite, Sofia Magina, Gabriela Marques Pinto, Hugo Oliveira, Artur Sousa Basto, Rui Tavares Bello, Paulo Varela, Antonio Massa, Manuela Selores, Paulo Filipe, On behalf of The Portuguese College of Dermatology, On behalf of The Portuguese Society of Dermatology and Venereology

Subjects: Get full text

Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators? by Dea Metko, Tiago Torres, Ronald Vender

“…Over the past two decades, promising advancements have emerged in the field of psoriasis management. Most notably, highly effective targeted biologic therapies that offered significant breakthroughs in the management of psoriasis have been developed. …”
Get full text

Biosimilar Agents for Psoriasis Treatment: The Perspective of Portuguese Patients by Alexandra Azevedo, Andreia Bettencourt, Manuela Selores, Tiago Torres

Subjects: Get full text

Management of psoriasis in pregnancy – a review of the evidence to date by Clara Ferreira, Alexandra Azevedo, Miguel Nogueira, Tiago Torres

Subjects: Get full text

Biologic therapy for psoriasis - still searching for the best target by Teresa Pinto-Almeida, Tiago Torres

Subjects: Get full text

Epidemiology of Psoriasis in Portugal: A Population-Based Study by Tiago Torres, Paulo Filipe, Francisco Menezes Brandão, Américo Figueiredo, António Pinto Soares, Artur Sousa Basto, Clarisse Rebelo, Osvaldo Correia, Paulo Ferreira, Ana Brasileiro, Pedro Mendes-Bastos, Maria João Paiva-Lopes, Gabriela Marques Pinto, Milton Severo, Denisa Mendonça, Pedro Oliveira, Manuela Selores, António Massa, Marta Pereira, Rui Tavares Bello, on behalf of the Portuguese Psoriasis Group of the Portuguese Society of Dermatology and Venereology

Subjects: Get full text

Risankizumab, a therapeutic alternative for psoriasis in people living with HIV by Tomás Estevinho, Egídio Freitas, Tiago Torres

“…The management of psoriasis in individuals with human immunodeficiency virus (HIV) presents a unique challenge, marked by a more severe progression and limited efficacy of first- and second-line treatments. …”
Get full text

Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents by Anastasia Drakos, Tiago Torres, Ronald Vender

Subjects: “…psoriasis…”
Get full text

Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study by Andrea Chiricozzi, Anna Balato, Curdin Conrad, Andrea Conti, Paolo Dapavo, Paulo Ferreira, Francesca Maria Gaiani, Luiz Leite, Piergiorgio Malagoli, Pedro Mendes-Bastos, Matteo Megna, Francesco Messina, Alessia Nidegger, Giulia Odorici, Salvatore Panduri, Stefano Piaserico, Leonardo Piscitelli, Francesca Prignano, Simone Ribero, Joana Valerio, Tiago Torres

Subjects: Get full text

Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors by Cláudia Oliveira Maçães, Ana Maria Lé, Tiago Torres

Subjects: “…generalized pustular psoriasis…”
Get full text

Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis by Ana Teixeira, Maribel Teixeira, Vera Almeida, Rita Gaio, Tiago Torres, Sofia Magina, Cátia Cunha, José M. Sousa Lobo, Isabel F. Almeida

Subjects: Get full text

Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review by Tiago Torres, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Paolo Gisondi, José Manuel Carrascosa, Bruno Halioua, Anthony Bewley, Andreas Pinter

Subjects: Get full text

Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study by Tiago Torres, Paulo Varela, Pedro Mendes Bastos, Sofia Magina, Martinha Henrique, Paulo Ferreira

Subjects: Get full text

Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp by Nuria García, Pere Guiró, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Tiago Torres

Subjects: Get full text

A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains by Tiago Torres, Tiago Torres, Anabela Barcelos, Anabela Barcelos, Anabela Barcelos, Paulo Filipe, Paulo Filipe, Paulo Filipe, João Eurico Fonseca, João Eurico Fonseca

Subjects: “…psoriasis…”
Get full text

Psoríase induzida por infliximab. by Iolanda C Fernandes, Tiago Torres, Madalena Sanches, Glória Velho, Paula Lago, Manuela Selores

“…The skin biopsy confirmed the clinical diagnosis of psoriasis. Given the severity of the skin lesions and its relation with the anti-TNF-α, we decided to discontinue infliximab.Psoriasis results from the combination of polygenic predisposition and several triggering factors. …”
Get full text

Deucravacitinib for the treatment of psoriatic arthritis: the evidence so far by Ana Martins, Ana Maria Lé, Tiago Torres

“…Psoriatic arthritis (PsA) is a heterogeneous disease that may develop in up to 30% of patients with psoriasis. PsA mainly involves peripheral joints; however, axial skeleton and entheses can also be involved. …”
Get full text

JAK/STAT inhibitors for the treatment of atopic dermatitis by Maria Alexandra Rodrigues, Tiago Torres

“…With a growing movement toward use of targeted therapies, parallel to psoriasis, JAK inhibitors are an important focus of therapeutic research for AD. …”
Get full text

Upadacitinib for the treatment of psoriatic arthritis by Diogo Fonseca, Miguel Nogueira, Tiago Torres

“…Psoriatic arthritis is a chronic systemic inflammatory disease that presents with a variable clinical course and is typically associated with joint inflammation, together with cutaneous psoriasis. In recent decades, knowledge of the pathogenesis of psoriatic arthritis has advanced considerably and has allowed for development of new highly effective therapies, transforming the treatment landscape. …”
Get full text